These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34956092)

  • 1. GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy.
    Savage MO; Storr HL
    Front Endocrinol (Lausanne); 2021; 12():781044. PubMed ID: 34956092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone/IGF-I axis and growth hormone receptor mutations in idiopathic short stature.
    El Kholy M; Mella P; Rashad M; Buzi F; Meazza C; Zahra S; Elsedfy HH
    Horm Res Paediatr; 2011; 76(5):300-6. PubMed ID: 21846964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GH-IGF-I axis in children with idiopathic short stature.
    Blair JC; Savage MO
    Trends Endocrinol Metab; 2002 Oct; 13(8):325-30. PubMed ID: 12217488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I (rhIGF-I) therapy of short stature.
    Rosenbloom AL
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):301-15. PubMed ID: 18556960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature.
    Goddard AD; Dowd P; Chernausek S; Geffner M; Gertner J; Hintz R; Hopwood N; Kaplan S; Plotnick L; Rogol A; Rosenfield R; Saenger P; Mauras N; Hershkopf R; Angulo M; Attie K
    J Pediatr; 1997 Jul; 131(1 Pt 2):S51-5. PubMed ID: 9255229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy?
    Savage MO; Camacho-Hübner C; David A; Metherell LA; Hwa V; Rosenfeld RG; Clark AJ
    Eur J Endocrinol; 2007 Aug; 157 Suppl 1():S33-7. PubMed ID: 17785695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
    Child CJ; Quigley CA; Cutler GB; Moore WV; Wintergerst KA; Ross JL; Rosenfeld RG; Blum WF
    Horm Res Paediatr; 2019; 91(4):241-251. PubMed ID: 31185471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphotyrosine phosphatases in GH-stimulated skin fibroblasts from children with idiopathic short stature.
    Ocaranza P; Gaete X; Román R; Morales F; Íñiguez G; Cassorla F
    J Pediatr Endocrinol Metab; 2013; 26(9-10):833-40. PubMed ID: 23729600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone receptor sequence changes do not play a role in determining height in children with idiopathic short stature.
    Hujeirat Y; Hess O; Shalev S; Tenenbaum-Rakover Y
    Horm Res; 2006; 65(4):210-6. PubMed ID: 16582564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic benefits of growth hormone therapy in idiopathic short stature.
    Dahlgren J
    Horm Res Paediatr; 2011; 76 Suppl 3():56-8. PubMed ID: 21912170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
    Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
    J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting bone age maturation during 3 years of growth hormone treatment in patients with idiopathic growth hormone deficiency and idiopathic short stature: Analysis of data from the LG growth study.
    Kang MJ; Kim EY; Shim YS; Jeong HR; Lee HJ; Yang S; Hwang IT
    Medicine (Baltimore); 2019 Apr; 98(14):e14962. PubMed ID: 30946320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
    Liu HJ; Wang LH; Chen L
    Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Challenge of Defining and Investigating the Causes of Idiopathic Short Stature and Finding an Effective Therapy.
    Inzaghi E; Reiter E; Cianfarani S
    Horm Res Paediatr; 2019; 92(2):71-83. PubMed ID: 31578025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
    Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
    Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology of short stature in Indian children and an assessment of the growth hormone-insulin-like growth factor axis in children with idiopathic short stature.
    Kumar A; Pal A; Kalaivani M; Gupta N; Jain V
    J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1009-1017. PubMed ID: 30130251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.